Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

NCT06217770 ·Status: COMPLETED

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

NCT06350825 ·Status: RECRUITING ·Phase: PHASE3

Biomarkers of Bone Resorption in Metastatic Prostate Cancer

NCT01233557 ·Status: COMPLETED

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

NCT03336983 ·Status: COMPLETED ·Phase: PHASE2

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

NCT00002924 ·Status: COMPLETED

Prostate Adenocarcinoma TransCutaneous Hormones

NCT00303784 ·Status: UNKNOWN ·Phase: PHASE3

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

NCT04220398 ·Status: UNKNOWN ·Phase: NA

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT00668083 ·Status: COMPLETED

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

NCT01006395 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma

NCT03718338 ·Status: TERMINATED

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

NCT00171639 ·Status: COMPLETED ·Phase: PHASE3

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

NCT01819285 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

NCT06834321 ·Status: RECRUITING ·Phase: PHASE2

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

NCT00223145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

NCT06306612 ·Status: RECRUITING ·Phase: NA

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

NCT00075192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

NCT07163910 ·Status: RECRUITING ·Phase: PHASE2

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2

Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer

NCT06807398 ·Status: COMPLETED

A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01834209 ·Status: NO_LONGER_AVAILABLE

Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases

NCT00685646 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

NCT00063609 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

NCT00630799 ·Status: TERMINATED ·Phase: PHASE3

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

NCT05707468 ·Status: NOT_YET_RECRUITING ·Phase: NA